Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease

Summary

This is a single patient compassionate use protocol to determine whether RAVICTI will improve bile flow in a subject who previously tolerated therapy with Buphenyl.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications